Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-03-13

FDA Approved: CHILDRENS ALLERGY RELIEF — Original Application (Strategic Sourcing Services)

View source ↗

Summary

FDA approves an Original ANDA for Cetirizine Hydrochloride marketed as Children's Allergy Relief from Strategic Sourcing Services.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CHILDRENS ALLERGY RELIEF (Cetirizine Hydrochloride)

Snippet

ORIG AP for CHILDRENS ALLERGY RELIEF (CETIRIZINE HYDROCHLORIDE)